Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: Angiographic results of the APRICOT study

This publication has 36 references indexed in Scilit:

• Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction
  The American Journal of Cardiology, 1988
• Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1987
• Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rate
  The American Journal of Cardiology, 1987
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.
  Circulation, 1986
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: Acute and follow-up studies
  The American Journal of Cardiology, 1984
• Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study.
  Heart, 1983
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980
• Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase
  Clinical Cardiology, 1979